MENU
+Compare
CPRX
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$20.29
Change
+$0.49 (+2.47%)
Capitalization
2.48B

CPRX Catalyst Pharmaceuticals Forecast, Technical & Fundamental Analysis

Catalyst Pharmaceuticals Inc is a biopharmaceutical company... Show more

CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CPRX with price predictions
Sep 04, 2025

CPRX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CPRX turned positive on August 20, 2025. Looking at past instances where CPRX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CPRX advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

CPRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CPRX as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for CPRX moved below the 200-day moving average on August 07, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.831) is normal, around the industry mean (20.013). P/E Ratio (12.000) is within average values for comparable stocks, (51.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.122). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (4.486) is also within normal values, averaging (326.881).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CPRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CPRX is expected to report earnings to fall 47.06% to 36 cents per share on November 05

Catalyst Pharmaceuticals CPRX Stock Earnings Reports
Q3'25
Est.
$0.36
Q2'25
Beat
by $0.29
Q1'25
Beat
by $0.34
Q4'24
Beat
by $0.38
Q3'24
Beat
by $0.27
The last earnings report on August 06 showed earnings per share of 68 cents, beating the estimate of 38 cents. With 2.37M shares outstanding, the current market capitalization sits at 2.48B.
A.I. Advisor
published General Information

General Information

a developer of prescription drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
355 Alhambra Circle
Phone
+1 305 420-3200
Employees
167
Web
https://www.catalystpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PURAX20.50N/A
N/A
PGIM Global Real Estate A
EGFIX46.32N/A
N/A
Edgewood Growth Instl
MBAYX13.92N/A
N/A
MassMutual Balanced Svc
CDAZX7.97N/A
N/A
Multi-Manager Directional Alt Strat Inst
AIVGX19.70N/A
N/A
American Funds International Vntg F-3

CPRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with SANA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+2.47%
SANA - CPRX
47%
Loosely correlated
-0.67%
VIR - CPRX
46%
Loosely correlated
+2.53%
CRNX - CPRX
43%
Loosely correlated
+3.97%
SYRE - CPRX
43%
Loosely correlated
+0.06%
LGND - CPRX
41%
Loosely correlated
-0.59%
More